Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan

被引:49
作者
Ismail, Mohammad [1 ]
Iqbal, Zafar [1 ]
Khattak, Muhammad Bilal [2 ]
Khan, Muhammad Imran [2 ]
Arsalan, Hassan [3 ]
Javaid, Arshad [4 ]
Gul, Qamar [5 ]
Khan, Faramoz [6 ]
机构
[1] Univ Peshawar, Dept Pharm, Peshawar, Khyber Pakhtunk, Pakistan
[2] Ayub Teaching Hosp, Ayub Med Coll, Abbottabad, Khyber Pakhtunk, Pakistan
[3] Sarhad Univ Sci & Informat Technol, Dept Pharm, Peshawar, Pakistan
[4] LRH, PGMI, Peshawar, Pakistan
[5] Univ Malakand, Dept Pharm, Chakdara, Khyber Pakhtunk, Pakistan
[6] Khyber Teaching Hosp, Med Unit B, Peshawar, Pakistan
关键词
Adverse drug interaction; Clinical pharmacy; Drug related problem; Pakistan; Potential drug-drug interaction; Prescriptions screening;
D O I
10.1007/s11096-013-9764-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Multiple drugs therapies may be the potential source of drug-drug interactions that can result in alteration of therapeutic response and/or increase untoward effects of many drugs. Objective To identify the frequency and levels of potential drug-drug interactions (pDDIs) in internal medicine wards and their association with patients' age, gender, length of hospital stay and number of prescribed medications; and to describe management of frequently identified major or moderate pDDIs. Setting Internal medicine wards of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan. Method Micromedex Drug-Reax system was used to screen patient's profiles for pDDIs. Logistic regression was applied to determine the odds ratio for specific risk factors of pDDIs i.e., age, gender, hospital-stay and number of medications. Main outcome measure Overall prevalence and prevalence of contraindicated, major, moderate and minor pDDIs; levels of pDDIs; frequently identified major or moderate interactions; and odds ratios for risk factors. Results Total, 188 interacting drug-combinations were identified that contributed to 675 pDDIs. Of 400 patients, 52.8 % patients were presented with at least one pDDI (overall prevalence), 21.3 % with at least one major-pDDI, and 44.3 % with at least one moderate-pDDI. Of 675 pDDIs, most were of moderate (63.6 %) or major severity (23 %); good (61.2 %) or fair (25.5 %) type of scientific evidence; and delayed onset (50.2 %). Most frequently identified major or moderate interactions resulted in 45.3 % of all pDDIs. Their potential adverse outcomes included hepatotoxicity, bleeding, ototoxicity, nephrotoxicity, hypoglycemia, hyperglycemia, risk of thrombosis, hypotension, cardiac arrhythmias and reduction in therapeutic-effectiveness. There was significant association of the occurrence of pDDIs with patients' age of 60 years or more (OR = 2.1; 95 % CI = 1.3-3.3; p = 0.003), hospital stay of 6 days or longer (OR = 2.6; 95 % CI = 1.5-4.5; p = 0.001), and seven or more number of prescribed medications (OR = 5.9; 95 % CI = 3.6-9.6; p < 0.001). Conclusion The present study has recorded a high prevalence of pDDIs in internal medicine wards. Patients with old age, longer hospital stay and increased number of prescribed medications were at higher risk.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 24 条
  • [1] [Anonymous], 2007, REPORT HLTH SYSTEM R
  • [2] [Anonymous], 2011, MICR DRUG REAX SYST, V150
  • [3] Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan?
    Babar, Zaheer-Ud-Din
    Jamshed, Shazia
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 617 - 619
  • [4] Baxter K., 2010, Stockley's Drug Interactions Pocket Companion 2010
  • [5] Hospitalisations and emergency department visits due to drug-drug interactions: a literature review
    Becker, Matthijs L.
    Kallewaard, Marjon
    Caspers, Peter W. J.
    Visser, Loes E.
    Leufkens, Hubert G. M.
    Stricker, Bruno HCh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) : 641 - 651
  • [6] Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece
    Chatsisvili, Anna
    Sapounidis, Ioakeim
    Pavlidou, Georgia
    Zoumpouridou, Eudoxia
    Karakousis, Vasileios-Alexandros
    Spanakis, Marios
    Teperikidis, Lefteris
    Niopas, Ioannis
    [J]. PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 187 - 193
  • [7] Creese A., 2004, The world medicines situation
  • [8] Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City
    Doubova , Svetlana Vladislavovna
    Reyes-Morales, Hortensia
    Torres-Arreola, Laura Del Pilar
    Suarez-Ortega, Magdalena
    [J]. BMC HEALTH SERVICES RESEARCH, 2007, 7 (1)
  • [9] Potential drug-drug interactions in the medication of medical patients at hospital discharge
    Egger, SS
    Drewe, J
    Schlienger, RG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (11) : 773 - 778
  • [10] Hansten PD, 2008, DRUG INTERACTIONS AN